LLY
5 August earnings table
Lilly
22,974 million, up 48 percent
Volume rose 60 percent. Realized prices fell 13 percent. Incretin medicines were 65 percent of first-half revenue. The 10-Q is the factory print. A share session is not.
The Long Read · 5 Sep
Volume and mix were off 8 points after the 5.6 billion Hostess deal. A Kroger dollar print does not grade the aisle.

Thesis map
A Zepbound fill still shrinks the calorie pool that snack bags count, while Foundayo is 98 million against 4,928 million.
Lilly sold 4,928 million dollars of Zepbound in the June quarter against 98 million of Foundayo. Worldwide revenue was 22,974 million, up 48 percent, on the 5 August table. Smucker printed Hostess Sweet Baked Snacks down 10 percent in fiscal 2026 first quarter. Circana still prints US snacks at 231 billion dollars, growing 3.2 percent in dollars. The scarce object is the fill line, not demand for the second pill.
The chain
Zepbound fill
Zepbound sold 4,928 million, up 46 percent. Mounjaro sold 9,943 million, up 91 percent. Combined tirzepatide was 14,871 million of 22,974 million. Fill-finish and the device stay scarce.
Calorie pool
Gallup put 11 percent of US adults currently taking a GLP-1 for weight loss, up from 3 percent two years earlier. Numerator has roughly two-thirds of former users stopping inside six months.
Snack bags
Smucker printed Hostess Sweet Baked Snacks down 10 percent, volume/mix off 8 points. Circana still prints US snacks at 231 billion dollars, growing 3.2 percent in dollars. Dollars are not bags.
Foundayo tablet
Foundayo is orforglipron. FDA approved it on 1 April 2026. NDA 220934. LillyDirect from 6 April. Self-pay from 149 dollars a month at the lowest dose. Medicare Part D as low as 50 dollars from 1 July.
Long side
Owns the scarce object. Named filing, named plant, named queue.
LLY
5 August earnings table
Lilly
22,974 million, up 48 percent
Volume rose 60 percent. Realized prices fell 13 percent. Incretin medicines were 65 percent of first-half revenue. The 10-Q is the factory print. A share session is not.
NVO
Novo Nordisk
Novo Nordisk and Eli Lilly sit on the other side of every grocery line. Prescriptions times the price they actually collect is the one number in this chain that is growing for sure.
long
Fill-finish
A prescription for tirzepatide can be written this afternoon. A filled pen cannot. Fill-finish is a sterile room, a qualified line, and a regulator who walks the floor. The device is a second constraint.
long
The device
The device stays scarce against 4,928 million of Zepbound and 98 million of Foundayo. The tablet has no refrigeration and no food or water restrictions. The pen still has a line.
Short side
Constrained by the chain, or a substitute that is not the product.
KR
Kroger bags
Kroger still reports grocery dollars. The aisle still counts bags. If the next grocer print is sales without units, the aisle is ungraded.
SJM
Hostess snacks
Sweet Baked Snacks -10 percent
Hostess already showed the tell. A script that cuts a snack basket can still leave a Costco card in a wallet. Volume is the observation, not the dollar print.
short
Circana
Snack dollars
231 billion, +3.2 percent
Circana growing 3.2 percent in dollars while Hostess units fall is the split. Treating the category dollar as the calorie pool hides the bag.
How they interconnect
Zepbound fillshrinksCalorie pool
A filled Zepbound pen shrinks the calorie pool. Gallup 11 percent is the stock of people already on a GLP-1, not the next script.
Calorie poolcutsSnack bags
A smaller calorie pool shows up in bags before it shows up in grocer dollars. Hostess Sweet Baked Snacks already fell 10 percent.
Foundayo tabletis not yetZepbound fill
Foundayo at 98 million is not Zepbound at 4,928 million. Naming the tablet on the June table was the product test. The factory test is the gap.
LillyfillsZepbound fill
Lilly fills Zepbound. Worldwide 22,974 million, up 48 percent, still has fill-finish as the scarce room.
Novo NordiskshrinksCalorie pool
Novo Nordisk shrinks the same calorie pool from the other pen. Prescriptions times realized price is the growing number.
Fill-finishgatesZepbound fill
Fill-finish gates the pen. A clinic can write the script. A sterile line has to stay qualified.
The devicegatesZepbound fill
The device is a second factory. Foundayo has no refrigeration. The pen still does.
Snack bagshides inKroger bags
Kroger dollars can hold while bags fall. Grocery dollars are not unit volume.
Snack bagshitsHostess snacks
Hostess is the tell on the aisle. Sweet Baked Snacks down 10 percent, volume/mix off 8 points.
Lillyis notSnack dollars
A 231 billion dollar snack category growing 3.2 percent in dollars is not the fill line. Do not flatten the category into the pen.
If you believe the thesis
The scarce object is still the fill line and the device, not demand for the second pill. Foundayo, approved 1 April 2026, NDA 220934, sold 98 million in its first named Key Product quarter. Ninety-eight million against 4,928 million is the factory test. Gallup, from May to June 2026, put 11 percent of US adults currently taking a GLP-1 for weight loss, up from 3 percent two years earlier.
If the thesis is incorrect
Two consecutive Lilly 10-Qs print Foundayo larger than Zepbound. Then the tablet was the product. A grocer 10-Q that names unit volume rising while Sweet Baked Snacks stay down would also spend the aisle leg. Do not flatten 98 million into 14,871 million of combined tirzepatide.
Kroger reports grocery dollars. The aisle claim is units. US packaged-snack volumes still have to print four consecutive year-over-year declines before the end of 2027. Two up volume quarters after any decline reset the count. Price-driven sales with falling bags count toward the claim, not against it.
Kroger can print dollars while the bag count falls.
Circana still prints US snacks at 231 billion dollars, growing 3.2 percent in dollars. Dollars are not units. Hostess, inside J.M. Smucker after a 5.6 billion dollar deal, already showed Sweet Baked Snacks down 10 percent in fiscal 2026 first quarter, with volume/mix off 8 points and price off 2. Hershey Q2 organic volume/mix was off 8. PepsiCo PFNA organic volume printed 0. Smucker, Coca-Cola, and Yum can still clear a screen in a week Staples leads. That rotation is real. It is not a picture of the aisle in 2029.
Gallup, May to June 2026, has current US adult GLP-1 use for weight loss at 11 percent, from 3 percent two years earlier. Fifteen percent have used one. Self-reported adult obesity is 36.4 percent, down from 39.9 percent in 2022. Numerator finds a current user in about 22 percent of households, grocery spend down about 4 percent in those homes, and roughly two-thirds stopping within six months. A grocer can print dollars while the bag count falls. A grocer can print dollars while the remaining bag is protein. Neither print is four down quarters in the category.
General Mills reports in September. Kraft Heinz, Mondelez, Hershey, PepsiCo, and Coca-Cola follow in October and November. Those filings are how the category clock moves. Nestle built Vital Pursuit for the drug and found four in five buyers are not on one. Volume and mix do not move on the same day. Kroger reports in six days. If that print is sales without units, the aisle is ungraded.
Kroger reports grocery dollars. The aisle still counts bags. Circana still prints US snacks at 231 billion dollars, growing 3.2 percent in dollars. Hostess already showed Sweet Baked Snacks down 10 percent, volume/mix off 8 points. If the next grocer print is sales without units, the aisle is ungraded.
Kroger can print dollars. The aisle still counts bags.